Precision BioSciences is developing mulitple DNE therapeutics targeted to enable the precise in situ correction of genes responsible for human disease.
More about BioTherapeutics >>
Engineered DNE meganucleases are being used to engineer cell lines for disease models or optimize cell lines for the biomanufacturing of protein vaccines and therapeutics.
More about BioTools >>
Custom DNE meganucleases produced by Precision BioSciences enable site-specific engineering of row crops and biofuel feedstocks.
More about PlantSciences >>
Precision BioSciences and Cellectis SA Announce Cross-License and Settlement Agreement for Gene Editing Technology
Precision BioSciences and DuPont Pioneer Announce Publication of Plant Genome Engineering Success
Precision BioSciences and DuPont Detail Technology Efficacy in The Plant Journal